Indegene Identified as a Leader in ISG Provider Lens™ for Life Sciences Digital Services in Commercial Operations – Digital Evolution (Service Providers) Quadrant 2026

Princeton, US, May 4, 2026: Information Services Group (ISG), a leading global technology research and advisory firm, has identified Indegene as a Leader in its Provider Lens™ for Life Sciences Digital Services in Commercial Operations – Digital Evolution (Service Providers) Quadrant 2026. The assessment highlights Indegene’s strong domain expertise, proprietary technology platforms, and growing use of AI and GenAI to enable more integrated, data-driven commercial operations for life sciences organizations.

The ISG Provider Lens™ report evaluates service providers based on their ability to help biopharmaceutical, biotech, and medical technology companies modernize commercial operations across planning, content, engagement, analytics, and execution through digital, data, and AI‑enabled models.

“Indegene shows a focused and capability-driven approach to life sciences commercial operations, supported by its proprietary platforms such as the NEXT Technology Platform and Cortex. These assets enable structured content management, workflow automation and more targeted HCP engagement through data-driven insights. The company’s long-standing domain experience is reflected in its ability to deliver across the commercial value chain, from planning to execution, with an emphasis on standardized processes and measurable outcomes. Its use of AI and GenAI in areas such as engagement planning, forecasting and analytics, along with a broad partner ecosystem, indicates a steady shift toward more integrated and data-led commercial models,” — Rohan Sinha, Principal Analyst – Healthcare and Life Sciences, ISG

Indegene’s offerings in commercial operations focus on helping life sciences enterprises move beyond fragmented digital initiatives toward orchestrated, intelligence‑led execution. Through its NEXT Technology Platform and Cortex, Indegene enables clients to connect content, data, workflows, and engagement across channels, supporting consistent execution, improved operational efficiency, and more meaningful HCP interactions.

“ISG’s recognition as a Leader affirms our belief that the future of life sciences commercial operations will be intelligence-led and AI-native by design.” said Vivek Ghai, EVP, Indegene. “As the industry accelerates toward fully connected, data-driven ecosystems, we are shaping this transformation - enabling our clients to operationalize data and analytics into real-world outcomes at scale, with speed, precision, and consistency.”

ISG’s recognition—for the third consecutive year—further reinforces Indegene’s position as a trusted partner for life sciences companies seeking to modernize commercial operations, improve engagement effectiveness, and deliver sustained business value through digital, data, and AI-led transformation.

To download the full report, click here.

Indegene Limited (BSE: 544172, NSE: INDGN) is the strategic operating partner to the life sciences industry, orchestrating commercial, medical, R&D, and safety operations across the product lifecycle. Trusted by the world’s top 20 biopharma companies, Indegene helps run complex, highly regulated workflows at global scale.

Indegene combines deep life sciences expertise with AI-embedded platforms and governed operating models to improve speed, consistency, and compliance across mission-critical operations. By integrating technology into how work is executed and scaled, Indegene enables life sciences organizations to deliver measurable outcomes in regulated environments.

For more information, visit www.indegene.com.